Abstract

Infectious diseases have long posed a significant threat to global health and require constant innovation in treatment approaches. However, recent groundbreaking research has shed light on a previously overlooked player in the pathogenesis of disease-the human microbiome. This review article addresses the intricate relationship between the microbiome and infectious diseases and unravels its role as a crucial mediator of host-pathogen interactions. We explore the remarkable potential of harnessing this dynamic ecosystem to develop innovative treatment strategies that could revolutionize the management of infectious diseases. By exploring the latest advances and emerging trends, this review aims to provide a new perspective on combating infectious diseases by targeting the microbiome.

MeSH

Communicable Diseases, Host-Pathogen Interactions

Cited by

• Dermatological Manifestations and Sebum Composition in Parkinson's Disease. Dermatol Pract Concept, 2025
• Multiple Strategies for the Application of Medicinal Plant-Derived Bioactive Compounds in Controlling Microbial Biofilm and Virulence Properties. Antibiotics (Basel), 2025
• Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug. Biomedicines, 2025
• The Impact of Antibiotic Therapy on Intestinal Microbiota: Dysbiosis, Antibiotic Resistance, and Restoration Strategies. Antibiotics (Basel), 2025
• Exploring the role of gut microbiota in antibiotic resistance and prevention. Ann Med, 2025
• Sustainable Nanotechnology Strategies for Modulating the Human Gut Microbiota. Int J Mol Sci, 2025
• Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome. Nat Med, 2025
• Navigating the Intersection of Lasers and the Skin Microbiome: A New Frontier in Esthetic Dermatology. J Cosmet Dermatol, 2025
• Extracellular DNA, hyaluronic acid, HIF pathways, and LncRNAs as predictive biomarkers of severe COVID-19. Virol J, 2025
• Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome. Res Sq, 2024
• Respiratory Microbiota and Health Risks in Children with Cerebral Palsy: A Narrative Review. Children (Basel), 2025
• Therapeutic targeting of the host-microbiota-immune axis: implications for precision health. Front Immunol, 2025
• The Global Burden of Periodontal Disease: A Narrative Review on Unveiling Socioeconomic and Health Challenges. Int J Environ Res Public Health, 2025
• Reinvigorating AMR resilience: leveraging CRISPR-Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security-a systematic review. Trop Med Health, 2025
• The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches. Front Immunol, 2025
• Could a Mediterranean Diet Modulate Alzheimer's Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration. Foods, 2025